1.3 Allergy Screening, Sensitivity Identification & Latex Precautions

Allergy Screening, Sensitivity Identification & Latex Precautions

Core Principle: Preoperative allergy screening is an active, investigative clinical interview rather than a passive clerical check. Perioperative nurses must accurately distinguish between life-threatening Type I IgE-mediated hypersensitivity, delayed Type IV cell-mediated contact dermatitis, and non-immune adverse drug side effects. Inaccurate documentation carries dual perils: exposing a sensitized patient to fatal intraoperative anaphylaxis, or erroneously withholding first-line surgical antibiotic prophylaxis due to a mislabeled drug allergy.

---

Immunological Hypersensitivity vs. Adverse Reactions

When a patient reports an "allergy," the perioperative nurse must immediately investigate the specific clinical manifestations, time of onset, and required medical interventions.

┌────────────────────────────────────────────────────────────────────────┐
│                     HYPERSENSITIVITY CLASSIFICATION                    │
├────────────────────┬────────────────────┬──────────────────────────────┤
│ TYPE               │ MECHANISM          │ CLINICAL MANIFESTATIONS      │
├────────────────────┼────────────────────┼──────────────────────────────┤
│ Type I (Immediate) │ IgE cross-linking; │ Urticaria, laryngeal edema,  │
│                    │ Mast cell/basophil │ stridor, severe bronchospasm,│
│                    │ degranulation      │ acute hypotension, collapse. │
├────────────────────┼────────────────────┼──────────────────────────────┤
│ Type IV (Delayed)  │ T-cell mediated;   │ Contact dermatitis, erythema,│
│                    │ Cytokine release   │ pruritus, vesicles at 24-72h.│
├────────────────────┼────────────────────┼──────────────────────────────┤
│ Adverse Drug Event │ Non-immunological; │ Opioid nausea/constipation,  │
│ (Side Effect)      │ Receptor mediated  │ NSAID dyspepsia, ACEI cough. │
└────────────────────┴────────────────────┴──────────────────────────────┘

Type I Hypersensitivity: Immediate IgE-Mediated Anaphylaxis

• Pathophysiological Cascade: Prior exposure to an allergen (e.g., natural rubber latex proteins, beta-lactam antibiotics, neuromuscular blocking agents) stimulates plasma cells to produce specific immunoglobulin E (IgE) antibodies that bind to high-affinity Fc receptors on tissue mast cells and circulating basophils. Upon re-exposure, the bivalent antigen cross-links adjacent IgE molecules, triggering explosive degranulation.
• Chemical Mediators Released: Preformed histamine, tryptase, and carboxypeptidase, followed by rapid de novo synthesis of leukotrienes (LTC₄, LTD₄, LTE₄), prostaglandin D₂, platelet-activating factor (PAF), and tumor necrosis factor-alpha (TNF-α).
• Clinical Presentation: Onset occurs within seconds to minutes following intravenous drug administration (or 30 to 60 minutes after mucosal latex absorption):
  • Dermatologic: Generalized urticaria (hives), intense pruritus, flushing, facial and periorbital angioedema.
  • Respiratory: Laryngeal edema, inspiratory stridor, tachypnea, severe bronchospasm, acute refractory hypoxemia.
  • Cardiovascular: Profound vasodilation, marked capillary extravasation (losing up to 35% of intravascular volume into interstitial spaces within 10 minutes), severe hypotension, compensatory tachycardia progressing to bradycardia and cardiovascular collapse.
• Emergency Medical Management:
  1. Immediately discontinue the inciting agent and call for help / summon the anesthesia team.
  2. Administer Epinephrine: First-line, life-saving intervention. For spontaneous breathing or pre-op holding patients, administer Epinephrine 0.3 to 0.5 mg IM (1:1,000 solution) into the anterolateral thigh. Under general anesthesia, the anesthesia provider administers intravenous epinephrine in titrated boluses (10 to 50 mcg IV for hypotension; 0.1 to 1.0 mg IV for cardiac arrest).
  3. Airway & Oxygenation: Maintain airway with 100% fraction of inspired oxygen (FiO₂); prepare for rapid endotracheal intubation before laryngeal edema distorts anatomy.
  4. Aggressive Volume Expansion: Infuse rapid boluses of isotonic crystalloids (Normal Saline or Lactated Ringer's, 1 to 2 liters rapidly in adults) to treat distributive shock.
  5. Secondary Medications: Administer H₁-antihistamines (diphenhydramine 25–50 mg IV), H₂-blockers (famotidine 20 mg IV), and corticosteroids (methylprednisolone 125 mg IV) to blunt biphasic anaphylactic reactions.

Type IV Hypersensitivity: Delayed Cell-Mediated Contact Dermatitis

• Mechanism: Mediated by sensitized T-lymphocytes, not antibodies. Upon re-exposure to the contact allergen, T-cells release inflammatory cytokines that recruit macrophages and neutrophils.
• Timeline: Symptoms peak 24 to 72 hours post-exposure.
• Clinical Presentation: Erythema, pruritic induration, papules, and vesicle formation localized to the exact area of contact (e.g., wristbands, surgical prep sites, surgical tape, rubber accelerator chemicals in non-latex or latex gloves [thiurams, carbamates]).
• Significance: Type IV reactions are uncomfortable but not immediately life-threatening. However, patients sensitized to natural rubber accelerators may also harbor or develop concurrent Type I IgE antibodies.

Adverse Drug Side Effects (Non-Immune Reactions)

A critical nursing role is de-escalating non-immune adverse effects mislabeled as "allergies":

• Opioid-Induced Nausea & Pruritus: Opioids (morphine, codeine) can cause non-immunological direct mast cell histamine release and stimulate the chemoreceptor trigger zone (CTZ). Nausea, vomiting, and mild facial itching are expected adverse effects, not true IgE-mediated anaphylaxis.
• NSAID-Induced Dyspepsia: Gastrointestinal irritation from prostaglandin inhibition is an adverse side effect; it does not preclude the perioperative use of alternative COX inhibitors.
• Vancomycin Infusion Reaction ("Red Man Syndrome"): Caused by non-immune histamine release triggered by an excessively rapid IV infusion rate (>10 mg/min or <60 minutes per 1 gram). Features erythematous flushing and pruritus of the face, neck, and upper torso. Corrected by slowing the infusion rate to 90–120 minutes and premedicating with antihistamines—it is not an allergic contraindication to vancomycin.

---

Latex Allergy: Epidemiology & High-Risk Populations

Natural rubber latex (NRL) is a milky fluid harvested from the rubber tree Hevea brasiliensis. NRL contains over 250 polypeptides, of which at least 15 are major antigenic proteins (Hev b 1 through Hev b 15).

┌────────────────────────────────────────────────────────────────────────┐
│                     LATEX ALLERGY HIGH-RISK COHORTS                    │
├────────────────────────────────────┬───────────────────────────────────┤
│ POPULATION AT RISK                 │ CLINICAL MECHANISM / REASON       │
├────────────────────────────────────┼───────────────────────────────────┤
│ Spina Bifida / Myelomeningocele    │ >30-50% sensitization rate from   │
│ & Congenital Urological Anomalies  │ early, repeated mucosal exposure   │
│                                    │ (Foley catheters, shunt surgeries)│
├────────────────────────────────────┼───────────────────────────────────┤
│ Multiple Surgical Procedures       │ Repeated exposure to surgical     │
│ (>5 Lifetime Surgeries)            │ gloves, drains, and catheters     │
├────────────────────────────────────┼───────────────────────────────────┤
│ Healthcare & Rubber Workers        │ Chronic occupational exposure to  │
│                                    │ aerosolized powdered latex gloves │
├────────────────────────────────────┼───────────────────────────────────┤
│ Latex-Fruit Cross-Reactivity       │ Shared epitope homology with      │
│ (Banana, Avocado, Kiwi, Chestnut)  │ plant defense proteins (hevein)   │
└────────────────────────────────────┴───────────────────────────────────┘

The Latex-Fruit Syndrome

Certain plants synthesize pathogenesis-related defense proteins (specifically class I endochitinases containing a hevein-like N-terminal domain) that share structural and conformational homology with Hev b 6.02 (the primary allergen in natural rubber latex). A patient with IgE antibodies targeting hevein cross-reacts when ingesting these fruits, and vice versa.

• High-Risk Cross-Reactive Foods: Banana, Avocado, Kiwi, and European Chestnut carry the strongest cross-reactivity association.
• Moderate-to-Low Risk Foods: Papaya, fig, tomato, raw potato, bell pepper, peach, melon, and mango.
• Nursing Action: Any patient reporting oral tingling, lip edema, or hives when eating bananas, kiwis, avocados, or chestnuts must be classified and managed as a presumed latex-allergic patient until formally evaluated.

---

Latex-Safe Environment Protocol in the ASC

Freestanding ambulatory surgery centers must establish rigorous operational protocols to protect latex-sensitive individuals from direct mucosal contact, cutaneous exposure, and aerosol inhalation.

1. Preoperative Identification & Signage:
   • Affix a prominent Red Allergy Identification Band to the patient's wrist.
   • Apply clear "LATEX ALLERGY PRECAUTIONS" warning signs on the outer entry doors of the pre-op bay, operating room suite, and PACU bay.
   • Activate EHR allergy alerts across pharmacy, nursing, and surgical portals.
2. Case Scheduling Protocol:
   • Schedule the patient as the FIRST CASE of the day.
   • Rationale: During the business day, donning and removing powdered latex gloves aerosolizes microscopic cornstarch particles bound to latex proteins. These particles remain suspended in ambient room air for hours. Overnight, positive-pressure HVAC filtration (minimum 20 total air exchanges per hour, with ≥4 outdoor air exchanges and HEPA filtration) scrubs the air, and airborne allergen particles settle onto surfaces, which undergo overnight terminal disinfection.
3. Operating Room Suite Preparation:
   • 100% Latex-Free Equipment: Ensure all equipment entering the sterile field or contacting the patient is manufactured from synthetic polymers (nitrile, neoprene, polyisoprene, silicone, polyurethane, vinyl).
   • Anesthesia Apparatus: Use certified latex-free anesthesia breathing bags, corrugated circuits, face masks, endotracheal tubes, laryngeal mask airways (LMAs), oral/nasal airways, and suction catheters. Ensure rubber stopper components on IV ports are non-latex.
   • Surgical Supplies: Verify that surgical gloves (scrub nurse, surgeon, assistants), Foley catheters, Penrose drains, tourniquets, bulb syringes, and wound dressings are completely latex-free.
4. Medication Preparation Safeguards:
   • Never puncture natural rubber stoppers on medication vials with needles. Inserting a needle through a rubber vial stopper "cores" microscopic rubber particles directly into the medication solution, which are then injected intravenously into the sensitized patient.
   • Pop off the metal vial collar and rubber stopper completely to draw up the medication, or use single-dose glass ampules or needleless vial adapters.

---

Chlorhexidine Gluconate (CHG) Sensitivities & Safe Alternatives

Chlorhexidine gluconate is the standard antiseptic agent for preoperative patient skin preparation and surgical site infection (SSI) reduction. However, CHG hypersensitivity is an increasingly recognized cause of unexplained perioperative contact dermatitis and intraoperative anaphylaxis.

Clinical Manifestations of CHG Allergy

• Cutaneous Reactions: Severe contact dermatitis, chemical burns, blistering, erythema, and pruritus at the surgical prep site.
• Systemic Anaphylaxis: Occurs predominantly when CHG comes into contact with mucosal surfaces or enters vascular access devices (e.g., insertion of CHG-impregnated central venous catheters, Foley catheter insertion with CHG lubricating jelly, or application to open deep wounds). Features rapid circulatory collapse, bronchospasm, and angioedema under anesthesia.

Safe Antiseptic Alternatives

When a patient has a documented or suspected allergy to chlorhexidine, the perioperative nurse must substitute an appropriate non-chlorhexidine skin antiseptic:

• Povidone-Iodine (Betadine): 10% povidone-iodine aqueous scrub and paint or 7.5% surgical scrub. Safe and highly effective.
• Iodine Povacrylex in Isopropyl Alcohol (e.g., DuraPrep): Film-forming iodophor solution providing rapid antimicrobial action and long-lasting persistence.
• 70% Isopropyl Alcohol Alone: Can be used for minor skin punctures or superficial procedures in patients with dual CHG and iodine hypersensitivities.
• Clinical Pearl Regarding "Iodine/Shellfish Allergies": A widely held historical myth suggested that patients allergic to seafood/shellfish are automatically allergic to iodine antiseptics and radiocontrast media. This has been completely debunked. Seafood allergy is an IgE-mediated response to the muscle protein tropomyosin, not elemental iodine. Povidone-iodine can be safely administered to shellfish-allergic patients unless they have a documented specific allergy to povidone or iodine antiseptics.

Absolute Anatomical Contraindications for CHG

Regardless of a patient's allergy status, chlorhexidine gluconate is strictly contraindicated in specific anatomical zones:

1. Middle and Inner Ear: CHG is highly ototoxic. Exposure through a perforated tympanic membrane causes permanent sensorineural deafness and vestibular destruction. Povidone-iodine is the mandatory prep for otological procedures.
2. Central Nervous System & Meninges: CHG is neurotoxic. Direct contact with spinal cord tissues, meninges, or cerebrospinal fluid triggers severe chemical arachnoiditis and encephalopathy. It must never be used for open spina bifida repairs or procedures involving direct dural breaches.
3. Ocular Tissues: Direct contact with the cornea causes permanent corneal chemical burns and endothelial opacity.

---

Antibiotic Allergies & Cephalosporin Cross-Reactivity

Approximately 10% of surgical patients report a history of "penicillin allergy." However, extensive immunological testing demonstrates that over 90% of these patients do not have true IgE-mediated penicillin allergies—either because the original childhood reaction was a non-immune viral exanthem, or because penicillin-specific IgE antibodies have naturally waned over a 10-year span.

Historically, textbooks taught that patients allergic to penicillin experienced a "10% cross-reactivity risk" with all cephalosporins. This figure was derived from flawed 1960s and 1970s laboratory studies in which early cephalosporin formulations were contaminated with trace penicillin during fungal fermentation.

The Science of R1 Side-Chain Cross-Reactivity

Contemporary pharmacological research confirms that allergic cross-reactivity between penicillins and cephalosporins is dictated by structural homology of their R1 side chains, not the core four-membered beta-lactam ring:

• Cefazolin (First-Generation Cephalosporin): Cefazolin has a completely unique R1 side chain (a thiadiazole ring) that shares no structural similarity with penicillin G, ampicillin, or amoxicillin.
• Negligible Cross-Reactivity: The true clinical cross-reactivity rate between penicillin and cefazolin is less than 1%.

Evidence-Based Preoperative Antibiotic Decision Protocol

Based on consensus guidelines from AORN, the American Society of Health-System Pharmacists (ASHP), the Surgical Infection Society (SIS), and the Infectious Diseases Society of America (IDSA):

1. Patients with Non-Severe Penicillin Reactions:
   • Manifestations: Childhood rash, mild maculopapular exanthem without hives, nausea, vomiting, family history of allergy, or reaction occurring >10 years ago without systemic compromise.
   • Clinical Action: Administer CEFALAZIN. Cefazolin remains the undisputed first-line agent for surgical site infection prophylaxis. Mislabeled patients denied cefazolin receive inferior second-line antibiotics, resulting in significantly higher rates of surgical site infections, Clostridioides difficile colitis, and acute kidney injury.
2. Patients with Severe Type I Anaphylaxis or SCAR:
   • Manifestations: Documented history of immediate IgE-mediated anaphylaxis (anaphylactic shock, laryngeal stridor, cardiovascular collapse) OR severe cutaneous adverse reactions (SCAR: Stevens-Johnson syndrome [SJS], Toxic Epidermal Necrolysis [TEN], or Drug Reaction with Eosinophilia and Systemic Symptoms [DRESS]).
   • Clinical Action: AVOID ALL BETA-LACTAMS. Do not administer cephalosporins, penicillins, or carbapenems.
   • Second-Line Non-Beta-Lactam Alternatives:
     • Vancomycin: 15 mg/kg IV (maximum 2 grams). Must be infused slowly over 60 to 120 minutes (initiated in pre-op holding within 120 minutes prior to surgical incision) to prevent infusion reactions and achieve bactericidal tissue levels.
     • Clindamycin: 900 mg IV infused over 30 minutes (initiated within 60 minutes prior to incision).